Table 3 Feasibility outcomes.

From: Can non-pharmacological comfort care replace fentanyl in LISA? The NONA-LISA feasibility study

 

No./total (%)

 
 

Fentanyl

Saline

Relative risk (95% CI)

Modified COMFORTneo score ≥14

4/8 (50)

3/9 (33)

1.5 (0.47, 4.76)

Administration of open-label fentanyl during the procedurea

0/8 (0)

2/9 (22)

0.22 (0.01, 4.04)

Expected intervention true

6/8 (75)

6/9 (67)

1.13 (0.61, 2.07)

  1. Feasibility outcomes of the NONA-LISA feasibility study, including 17 infants from two Danish neonatal intensive care units from September 2023 to May 2024.
  2. CI confidence interval, NONA-LISA NON-pharmacological Approach to Less Invasive Surfactant Administration.
  3. aRelative risk was calculated after applying a continuity correction involving adding the value ‘0.5’ to all cells in this row to avoid division by zero.
Back to article page